Klor-con and Macular oedema - a phase IV clinical study of FDA data

Summary:

Macular oedema is reported as a side effect among people who take Klor-con (potassium chloride), especially for people who are female, 60+ old, also take Synthroid, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Macular oedema when taking Klor-con. It is created by eHealthMe based on reports of 27,036 people who have side effects when taking Klor-con from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Macular oedema?

Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken) is found to be associated with 438 drugs and 860 conditions by eHealthMe. Check the latest studies of Macular oedema.

On Jul, 15, 2026

27,036 people reported to have side effects when taking Klor-con.
Among them, 18 people (0.07%) have Macular oedema.

Among these 18 people:

What is the gender of people who have Macular oedema when taking Klor-con? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Macular oedema when taking Klor-con? *

What are other drugs people take besides Klor-con? *

What are other side effects people have besides Macular oedema? *

Macular Fibrosis (a thin sheet of scar tissue forms on top of the macula, in response to damage or injury): 6 people, 33.33%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 5 people, 27.78%
Adverse Event: 4 people, 22.22%
Vision Blurred: 4 people, 22.22%
Osteopenia (a condition where bone mineral density is lower than normal): 4 people, 22.22%
Headache (pain in head): 4 people, 22.22%
Blindness: 3 people, 16.67%
Insomnia (sleeplessness): 3 people, 16.67%
Chorioretinopathy (collection of fluid under the retina that results in visual distortion): 3 people, 16.67%
Hypophysitis (inflammation of the pituitary gland): 3 people, 16.67%

What are the existing conditions these people have? *

High Blood Cholesterol: 7 people, 38.89%
Diabetes: 5 people, 27.78%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 4 people, 22.22%
Blood Potassium Abnormal: 4 people, 22.22%
Bone Disorder: 4 people, 22.22%
Thyroid Diseases: 4 people, 22.22%
Malignant Pituitary Tumor: 4 people, 22.22%
Agitation (state of anxiety or nervous excitement): 3 people, 16.67%
Blepharitis (chronic inflammation of the eyelid): 3 people, 16.67%
Fungal Nail Infection: 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and have Macular oedema?

- Check whether Macular oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Klor-con:

Klor-con (27,547 reports)

Macular oedema treatments and more:

Macular oedema (10,661 reports)

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Macular oedema:

Macular oedema (438 drugs)

Browse all the conditions that are associated with Macular oedema:

Macular oedema (860 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Klor-con) and Klor-con (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.